Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
---|---|---|---|---|---|
Net Income | -217.31% | -- | -- | -- | |
Total Depreciation and Amortization | -- | -- | -- | -- | |
Total Amortization of Deferred Charges | -- | -- | -- | -- | |
Total Other Non-Cash Items | 930.42% | -- | -- | -- | |
Change in Net Operating Assets | -725.76% | -- | -- | -- | |
Cash from Operations | -157.66% | -- | -- | -- | |
Capital Expenditure | -- | -- | -- | -- | |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | |
Divestitures | -- | -- | -- | -- | |
Other Investing Activities | -- | -- | -- | -- | |
Cash from Investing | -- | -- | -- | -- | |
Total Debt Issued | -- | -- | -- | -- | |
Total Debt Repaid | -- | -- | -- | -- | |
Issuance of Common Stock | 1,368.93% | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | |
Issuance of Preferred Stock | -60.03% | -- | -- | -- | |
Repurchase of Preferred Stock | -- | -- | -- | -- | |
Total Dividends Paid | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | |
Cash from Financing | 139.73% | -- | -- | -- | |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
Net Change in Cash | -46.25% | -- | -- | -- | |